World’s first clinical based COVID-19 vaccine trials on volunteers has been completed successfully at Sechenov First Moscow State Medical University, said Vadim Trasov, the director of the Institute for Translational Medicine and Biotechnology. As mentioned by the Sputnik News Agency, Trasov also highlighted that the first batch of volunteers would be discharged on Wednesday and the second batch on 20th July 2020.
The primary essence of the trial and research was to show the vaccine’s safety for human health, which fortunately turned out to be successful, said Alexander Lukashev who is the director at the Sechenov University of the Institute of Medical Parasitology, Tropical and Vector-Borne Diseases. It has been confirmed by the Russian University that the vaccine is completely safe for human health, and it is relatively analogous to the ones that are presently available in the markets and hospitals.
Officially, the clinical trials of the COVID-19 vaccine produced by Russia’s Gamalei Institute of Epidemiology and Microbiology began at the Sechenov University on the 18 June and were successfully completed on Sunday, 12 July 2020. After several preclinical research and trials, and protocol developments, there came the success story of the COVID-19 vaccine.
The developer’s strategy is already working on the further development plan for the vaccine, including the complexity of the epidemiological situation with the virus and the possibility of advancement in the production, Lukashev pointed out.
In this critical situation of pandemic and people easily going into the clutches of the deadly virus, the Sechenov University of Russia has done a brilliant job in making efforts to help mankind. The university played an essential part not only as an educational institution but also as a scientific and technological research centre in providing a helping hand for the successful creation of a crucially required vaccine.
How many affected
The novel coronavirus has affected more than 12 million people across the globe. Although Russia is in the first place to complete its vaccine trials on volunteers successfully, in the last month of June the World Health Organisation (WHO) had declared that the vaccine being produced at Oxford was one of the most advanced. And, it is also being expected that soon it will be coming up with its successful vaccine as the AstraZeneca by Oxford is in its third phase of clinical trials.
Other authorities like Gilead Sciences, Oxford University’s researchers, and American biotech company Moderna are cutting the edge in the development of the corona vaccine. The antiviral Remdesivir COVID-19 drug produced by Gilead Sciences has helped in the recovery of patients and reduce the death risks in patients suffering severe illness due to COVID-19, but more clinical trials are required to confirm the benefits of the drug, said the Gilead Sciences Inc. There are more than hundreds of vaccines being developed or undertrials throughout the world, trying hard to help the human health and overcome the crisis.